|
1DW4
NMR STRUCTURE OF OMEGA-CONOTOXIN MVIIA: CONSTRAINTS ON DISULPHIDE BRIDGES
Deposited 2000-01-24
|
Different construct
Different experimental conditions
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–25(25 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 3.5;283 K;Ionic strength (raw mmCIF value) 0;Pressure ambient
NMR sample composition
1 | H2O (10% D2O)
NMR sample composition
1 | D2O
|
Resolution not provided
|
|
1DW5
NMR STRUCTURE OF OMEGA-CONOTOXIN MVIIA: NO CONSTRAINTS ON DISULPHIDE BRIDGES
Deposited 2000-01-24
|
Different construct
Different experimental conditions
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–25(25 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 3.5;283 K;Ionic strength (raw mmCIF value) 0;Pressure AMBIENT
NMR sample composition
1
|
Resolution not provided
|
|
1FEO
Solution structure of omega-conotoxin MVIIA with C-terminal Gly
Deposited 2000-07-21
|
Different construct
Different mutation/modification
Different experimental conditions
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–25(25 aa)
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 6;283 K;Pressure ambient
NMR sample composition
2 mM omega-MVIIA-Gly | 93% H2O, 7% D20
NMR sample composition
2 mM omega-MVIIA-Gly U-15N | 93% H2O, 7% D20
|
Resolution not provided
|
|
1MVI
N-TYPE CALCIUM CHANNEL BLOCKER, OMEGA-CONOTOXIN MVIIA, NMR, 15 STRUCTURES
Deposited 1996-08-02
|
Different construct
Different experimental conditions
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–25(25 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 3;293 K
|
Resolution not provided
|
|
1OMG
NMR STUDY OF OMEGA-CONOTOXIN MVIIA
Deposited 1995-04-26
|
Different construct
Different experimental conditions
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–25(25 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
SOLUTION NMR
mmCIF provides none of the parsed conditions
|
Resolution not provided
|
|
1TT3
NMR soulution structure of omega-conotoxin [K10]MVIIA
Deposited 2004-06-21
|
Different mutation/modification
Different experimental conditions
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
46–70(25 aa)
|
Mutation:R10K
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 3.5;293 K;Pressure ambient
NMR measurement conditions
pH 3.5;280 K;Pressure ambient
NMR sample composition
2mM [K10]MVIIA, 95% H2O, 5% D2O, DSS | 95% H2O/5% D2O
NMR sample composition
2mM [K10]MVIIA, 100% D2O, DSS | 100% D2O
|
Resolution not provided
|
|
7MIX
Human N-type voltage-gated calcium channel Cav2.2 in the presence of ziconotide at 3.0 Angstrom resolution
Deposited 2021-04-18
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain B
46–70(25 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3
CA CALCIUM ION × 2
Y01 CHOLESTEROL HEMISUCCINATE × 2
CLR CHOLESTEROL × 5
3PE 1,2-Distearoyl-sn-glycerophosphoethanolamine × 2
PT5 [(2R)-1-octadecanoyloxy-3-[oxidanyl-[(1R,2R,3S,4R,5R,6S)-2,3,6-tris(oxidanyl)-4,5-diphosphonooxy-cyclohexyl]oxy-phospho ryl]oxy-propan-2-yl] (8Z)-icosa-5,8,11,14-tetraenoate × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE;blot for 6 seconds before plunging
|
Resolution 3.00 Å
|
|
7VFU
Human N-type voltage gated calcium channel CaV2.2-alpha2/delta1-beta1 complex, bound to ziconotide
Deposited 2021-09-13
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain E
46–70(25 aa)
|
Not recorded
|
R16 HEXADECANE × 18
Y01 CHOLESTEROL HEMISUCCINATE × 3
PT5 [(2R)-1-octadecanoyloxy-3-[oxidanyl-[(1R,2R,3S,4R,5R,6S)-2,3,6-tris(oxidanyl)-4,5-diphosphonooxy-cyclohexyl]oxy-phospho ryl]oxy-propan-2-yl] (8Z)-icosa-5,8,11,14-tetraenoate × 1
CA CALCIUM ION × 2
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 8
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.00 Å
|